{"id":18553,"date":"2024-11-20T11:40:50","date_gmt":"2024-11-20T06:10:50","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=18553"},"modified":"2025-10-10T16:05:31","modified_gmt":"2025-10-10T10:35:31","slug":"ards-epidemiological-trends-and-risk-factors","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors","title":{"rendered":"Rising Acute Respiratory Distress Syndrome (ARDS) Prevalence Posing a Major Public Health Concern"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_76 counter-hierarchy ez-toc-counter ez-toc-white ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-69fd59db38e59\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-69fd59db38e59\"  aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors\/#Acute_Respiratory_Distress_Syndrome_Epidemiology_Insights\" >Acute Respiratory Distress Syndrome Epidemiology Insights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors\/#Driving_Factors_and_Epidemiological_Trends_for_ARDS_Prevalence\" >Driving Factors and Epidemiological Trends for ARDS Prevalence<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors\/#Way_ahead\" >Way ahead<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors\/#FAQs\" >FAQs<\/a><\/li><\/ul><\/nav><\/div>\n\n<p>The<strong> acute respiratory distress syndrome (ARDS)<\/strong> <strong>prevalence <\/strong>is increasing every year; it is estimated that in the United States alone, about <strong>190K<\/strong> Americans are diagnosed with ARDS each year. Prior to the COVID-19 global pandemic, more than <strong>700K<\/strong> individuals in the US and <strong>2 million cases<\/strong> globally developed ARDS from trauma, sepsis, bacterial, and viral infections, with a cumulative mortality of <strong>40%<\/strong>. The <a href=\"https:\/\/www.delveinsight.com\/covid19\">COVID-19 pandemic<\/a> has highlighted several severe unmet needs in the ARDS domain these include starting with the lack of effective <strong>FDA-approved pharmacotherapies<\/strong>, as neither SARS-CoV-2 vaccinations nor anti-SARS-CoV-2 vaccines address the unregulated inflammation that promotes multiorgan failure and ARDS death.&nbsp;<\/p>\n\n\n\n<p>Despite recent advances in translational research and exponential growth in the identification of new biomarkers, precision medicine approaches to ARDS have yet to be deployed, and validated ARDS biomarkers are lacking. This critical <a href=\"https:\/\/www.delveinsight.com\/blog\/acute-respiratory-distress-syndrome-market-landscape\">unmet need in ARDS<\/a> emphasizes a crucial gap between the rapid rate of biomarker discovery and effective translation to clinical application, as well as the need for biomarkers to influence a more streamlined drug approval process. The absence of accurate and validated ARDS biomarkers is one of the many reasons why clinical studies in ARDS fail.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-acute-respiratory-distress-syndrome-epidemiology-insights\"><span class=\"ez-toc-section\" id=\"Acute_Respiratory_Distress_Syndrome_Epidemiology_Insights\"><\/span><strong>Acute Respiratory Distress Syndrome Epidemiology Insights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>In 2023, the <a href=\"https:\/\/www.delveinsight.com\/report-store\/acute-respiratory-distress-syndrome-ards-epidemiology-forecast\">total incident cases of <strong>Acute Respiratory Distress Syndrome<\/strong><\/a>in the United States were approximately <strong>591 thousand<\/strong>. The United States accounted for the largest share of the <strong>ARDS<\/strong> population, representing about <strong>62%<\/strong> of the total cases across the <strong>7MM<\/strong> (United States, EU4, UK, and Japan). Meanwhile, the <strong>EU4<\/strong> countries (Germany, France, Italy, and Spain) and the <strong>UK<\/strong>, along with <strong>Japan<\/strong>, contributed approximately <strong>34%<\/strong> and <strong>4%<\/strong> of the total <strong>Acute Respiratory Distress Syndrome market<\/strong> share in 2023, respectively.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><img decoding=\"async\" width=\"1024\" height=\"365\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111630\/Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-7mm-1024x365.png\" alt=\"Acute Respiratory Distress Syndrome Epidemiological Insights (7mm)\" class=\"wp-image-30385\" style=\"width:840px;height:auto\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111630\/Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-7mm-1024x365.png 1024w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111630\/Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-7mm-300x107.png 300w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111630\/Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-7mm-150x54.png 150w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111630\/Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-7mm-768x274.png 768w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111630\/Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-7mm-1536x548.png 1536w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111630\/Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-7mm-2048x731.png 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"492\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111744\/EU5-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-EU5-1024x492.png\" alt=\"(EU5) Acute Respiratory Distress Syndrome Epidemiological Insights (EU5)\" class=\"wp-image-30386\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111744\/EU5-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-EU5-1024x492.png 1024w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111744\/EU5-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-EU5-300x144.png 300w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111744\/EU5-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-EU5-150x72.png 150w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111744\/EU5-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-EU5-768x369.png 768w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111744\/EU5-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-EU5-1536x738.png 1536w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111744\/EU5-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-EU5-2048x983.png 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p><\/p>\n\n\n\n<p>In 2023, there were <strong>177,000<\/strong> cases of acute respiratory distress syndrome (ARDS) in the U.S. classified as mild severity. This distribution highlights the varying treatment approaches required, ranging from less intensive care for mild cases to more aggressive interventions for severe cases.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"245\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111855\/Severity-Specific-Total-Incident-Cases-in-the-US-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-in-2023-1024x245.png\" alt=\"(Severity-Specific Total Incident Cases in the US) Acute Respiratory Distress Syndrome Epidemiological Insights (in 2023)\" class=\"wp-image-30387\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111855\/Severity-Specific-Total-Incident-Cases-in-the-US-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-in-2023-1024x245.png 1024w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111855\/Severity-Specific-Total-Incident-Cases-in-the-US-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-in-2023-300x72.png 300w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111855\/Severity-Specific-Total-Incident-Cases-in-the-US-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-in-2023-150x36.png 150w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111855\/Severity-Specific-Total-Incident-Cases-in-the-US-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-in-2023-768x184.png 768w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111855\/Severity-Specific-Total-Incident-Cases-in-the-US-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-in-2023-1536x367.png 1536w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20111855\/Severity-Specific-Total-Incident-Cases-in-the-US-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-in-2023-2048x490.png 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>DelveInsight estimates indicate that <strong>210,000<\/strong> incident cases of ARDS in the U.S. in 2023 were primarily caused by <a href=\"https:\/\/www.delveinsight.com\/report-store\/pneumonia-epidemiology-forecast\">pneumonia<\/a>, followed by <a href=\"https:\/\/www.delveinsight.com\/report-store\/sepsis-epidemiology-forecast\">sepsis<\/a>, aspiration, and other contributing factors. Additionally, cases with unknown origins also made up a significant portion of the total.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"468\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20112017\/Risk-Factors-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-in-2023-1024x468.png\" alt=\"(Risk Factors) Acute Respiratory Distress Syndrome Epidemiological Insights (in 2023)\" class=\"wp-image-30388\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20112017\/Risk-Factors-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-in-2023-1024x468.png 1024w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20112017\/Risk-Factors-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-in-2023-300x137.png 300w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20112017\/Risk-Factors-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-in-2023-150x69.png 150w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20112017\/Risk-Factors-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-in-2023-768x351.png 768w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20112017\/Risk-Factors-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-in-2023-1536x702.png 1536w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2022\/08\/20112017\/Risk-Factors-Acute-Respiratory-Distress-Syndrome-Epidemiological-Insights-in-2023-2048x936.png 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-driving-factors-and-epidemiological-trends-for-ards-prevalence\"><span class=\"ez-toc-section\" id=\"Driving_Factors_and_Epidemiological_Trends_for_ARDS_Prevalence\"><\/span><strong>Driving Factors and Epidemiological Trends for ARDS Prevalence<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>Pneumonia, Sepsis, Aspiration, Trauma, Pancreatitis, <\/strong>and others are among the major driving factors for ARDS prevalence. With the increase in the cases of these factors, the prevalence of ARDS is expected to rise in the coming years. As a result, the <a href=\"https:\/\/www.delveinsight.com\/report-store\/acute-respiratory-distress-syndrome-ards-epidemiology-forecast\">future trend of ARDS epidemiology<\/a> is anticipated to be the same, but pneumonia and sepsis are expected to be key factors for the surge in the ARDS prevalence by 2034.&nbsp;<\/p>\n\n\n\n<p>Other the other hand, acute respiratory failure-related mortality has increased at a rate of around <strong>3.4%<\/strong> per year, and there has been no drop in ARDS-related mortality in the previous five years. This concerning tendency is constant across age, gender, race and ethnicity, urbanization, and geographical regions. Identifying these tendencies and adjusting public health and policy planning efforts to them may assist to direct resource and infrastructure organization for the massive morbidity and death burden that is projected in the United States with the full-scale of ARF and ARDS linked with COVID-19.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-way-ahead\"><span class=\"ez-toc-section\" id=\"Way_ahead\"><\/span><strong>Way ahead<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Acute respiratory failure (ARF) is a critical condition that often sends patients straight to the ICU, where they face the harsh reality of mechanical ventilation. When ARF is caused by severe lung damage, it progresses into a life-threatening condition known as Acute Respiratory Distress Syndrome (ARDS). ARDS is an inflammatory disease that leads to fluid buildup in the lungs, making it difficult for oxygen to reach the bloodstream. It results in hypoxemia\u2014low oxygen levels\u2014and can leave patients struggling for breath, often with a poor prognosis. Historically, ARDS has been one of the leading causes of ARF, affecting nearly 3 million people every year. This disease is responsible for 10% of ICU admissions and 24% of mechanical ventilation cases, with a staggering mortality rate of 35-46%, depending on the severity of the disease when it strikes.<\/p>\n\n\n\n<p>Once, the COVID-19 pandemic was a major driving force behind the surge in ARDS cases, with patients experiencing severe respiratory distress due to viral pneumonia. However, with the pandemic subsiding, pneumonia has now become the predominant cause of ARDS in many cases, alongside other pulmonary and nonpulmonary causes such as trauma, pancreatitis, and sepsis. Despite significant advances in understanding the pathogenesis, development, and <a href=\"https:\/\/www.delveinsight.com\/report-store\/acute-respiratory-distress-syndrome-ards-market\">therapy of ARDS<\/a> and ARF, current statistics on the mortality burden of ARF and ARDS in the United States are inadequate. There remains a significant gap in comprehensive data, particularly after the adoption of the Berlin criteria for ARDS diagnosis. These gaps are concerning, especially given the role of geographic disparities in the quality of care. Different regions have varying access to critical care resources, which can heavily influence outcomes for ARDS patients.<\/p>\n\n\n\n<p>The burden of ARDS is high, but the clinical landscape continues to evolve. Pneumonia has emerged as a significant contributor to ARDS, reshaping the way we approach treatment and management. Advances in research and clinical practices are slowly chipping away at the high mortality rates, but with ongoing infrastructural challenges, especially in the ICU, much work remains to be done. This evolving story of ARDS highlights the need for continuous improvements in healthcare systems, better data collection, and more focused attention on how regional differences impact care, ultimately striving for a world where ARDS no longer carries such a heavy toll.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/acute-respiratory-distress-syndrome-ards-market\"><img decoding=\"async\" width=\"1024\" height=\"194\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2021\/01\/20110611\/Acute-Respiratory-Distress-Syndrome-Market-Outlook-1024x194.png\" alt=\"Acute Respiratory Distress Syndrome Market Outlook\" class=\"wp-image-30378\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2021\/01\/20110611\/Acute-Respiratory-Distress-Syndrome-Market-Outlook-1024x194.png 1024w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2021\/01\/20110611\/Acute-Respiratory-Distress-Syndrome-Market-Outlook-300x57.png 300w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2021\/01\/20110611\/Acute-Respiratory-Distress-Syndrome-Market-Outlook-150x28.png 150w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2021\/01\/20110611\/Acute-Respiratory-Distress-Syndrome-Market-Outlook-768x145.png 768w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2021\/01\/20110611\/Acute-Respiratory-Distress-Syndrome-Market-Outlook-1536x291.png 1536w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2021\/01\/20110611\/Acute-Respiratory-Distress-Syndrome-Market-Outlook.png 1584w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-faqs\"><span class=\"ez-toc-section\" id=\"FAQs\"><\/span>FAQs<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1760092487929\"><strong class=\"schema-faq-question\"><strong>How is ARDS diagnosed?<\/strong><\/strong> <p class=\"schema-faq-answer\">Diagnosis involves clinical assessment, imaging studies like chest X-rays or CT scans, and exclusion of other causes of respiratory distress.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1760092496614\"><strong class=\"schema-faq-question\"><strong>How many cases of ARDS occur annually in the U.S.?<\/strong><\/strong> <p class=\"schema-faq-answer\">In 2023, there were approximately 210K incident cases of ARDS in the U.S.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1760092506971\"><strong class=\"schema-faq-question\"><strong>What is the severity distribution of ARDS cases?<\/strong><\/strong> <p class=\"schema-faq-answer\">In 2023, 177K cases were classified as mild, highlighting the varying treatment approaches required.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1760092517957\"><strong class=\"schema-faq-question\"><strong>Has COVID-19 significantly impacted ARDS prevalence?<\/strong><\/strong> <p class=\"schema-faq-answer\">While COVID-19 initially led to a surge in ARDS cases, its impact has diminished as COVID-19 cases have virtually disappeared, with longstanding risk factors now being more prominent.<\/p> <\/div> <\/div>\n","protected":false},"excerpt":{"rendered":"<p>The acute respiratory distress syndrome (ARDS) prevalence is increasing every year; it is estimated that in the United States alone, about 190K Americans are diagnosed with ARDS each year. Prior to the COVID-19 global pandemic, more than 700K individuals in the US and 2 million cases globally developed ARDS from trauma, sepsis, bacterial, and viral [&hellip;]<\/p>\n","protected":false},"author":20,"featured_media":30391,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":8,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[12149,12146,19659,19660,10830,4502,18836],"industry":[17225],"therapeutic_areas":[17243],"class_list":["post-18553","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-acute-respiratory-distress-syndrome-2","tag-ards","tag-ards-epidemiology","tag-ards-prevalence","tag-covid-19","tag-pneumonia","tag-sepsis","industry-pharmaceutical","therapeutic_areas-respiratory-diseases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Understanding the Major Factors and Trends Driving the ARDS<\/title>\n<meta name=\"description\" content=\"Acute respiratory distress syndrome (ARDS) prevalence is increasing drastically owing to certain factors such as pneumonia, COVID-19, sepsis,\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Understanding the Major Factors and Trends Driving the ARDS\" \/>\n<meta property=\"og:description\" content=\"Acute respiratory distress syndrome (ARDS) prevalence is increasing drastically owing to certain factors such as pneumonia, COVID-19, sepsis,\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-20T06:10:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-10T10:35:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/11\/20114223\/Rising-Acute-Respiratory-Distress-Syndrome-ARDS-Prevalence-Posing-a-Major-Public-Health-Concern.png\" \/>\n\t<meta property=\"og:image:width\" content=\"466\" \/>\n\t<meta property=\"og:image:height\" content=\"284\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Jatin Vimal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jatin Vimal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Understanding the Major Factors and Trends Driving the ARDS","description":"Acute respiratory distress syndrome (ARDS) prevalence is increasing drastically owing to certain factors such as pneumonia, COVID-19, sepsis,","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors","og_locale":"en_US","og_type":"article","og_title":"Understanding the Major Factors and Trends Driving the ARDS","og_description":"Acute respiratory distress syndrome (ARDS) prevalence is increasing drastically owing to certain factors such as pneumonia, COVID-19, sepsis,","og_url":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2024-11-20T06:10:50+00:00","article_modified_time":"2025-10-10T10:35:31+00:00","og_image":[{"width":466,"height":284,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/11\/20114223\/Rising-Acute-Respiratory-Distress-Syndrome-ARDS-Prevalence-Posing-a-Major-Public-Health-Concern.png","type":"image\/png"}],"author":"Jatin Vimal","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"Jatin Vimal","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["WebPage","FAQPage"],"@id":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors","url":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors","name":"Understanding the Major Factors and Trends Driving the ARDS","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/11\/20114223\/Rising-Acute-Respiratory-Distress-Syndrome-ARDS-Prevalence-Posing-a-Major-Public-Health-Concern.png","datePublished":"2024-11-20T06:10:50+00:00","dateModified":"2025-10-10T10:35:31+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/c846f0323e948c55336d657b654f3158"},"description":"Acute respiratory distress syndrome (ARDS) prevalence is increasing drastically owing to certain factors such as pneumonia, COVID-19, sepsis,","mainEntity":[{"@id":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors#faq-question-1760092487929"},{"@id":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors#faq-question-1760092496614"},{"@id":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors#faq-question-1760092506971"},{"@id":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors#faq-question-1760092517957"}],"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/11\/20114223\/Rising-Acute-Respiratory-Distress-Syndrome-ARDS-Prevalence-Posing-a-Major-Public-Health-Concern.png","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/11\/20114223\/Rising-Acute-Respiratory-Distress-Syndrome-ARDS-Prevalence-Posing-a-Major-Public-Health-Concern.png","width":466,"height":284,"caption":"Rising Acute Respiratory Distress Syndrome (ARDS) Prevalence Posing a Major Public Health Concern"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/c846f0323e948c55336d657b654f3158","name":"Jatin Vimal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/10dcf4b5071c366691525fa20af33b87e8a3897e6d0acc1a2b09a7b99b8d8ae1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/10dcf4b5071c366691525fa20af33b87e8a3897e6d0acc1a2b09a7b99b8d8ae1?s=96&d=mm&r=g","caption":"Jatin Vimal"},"sameAs":["https:\/\/www.delveinsight.com"]},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors#faq-question-1760092487929","position":1,"url":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors#faq-question-1760092487929","name":"How is ARDS diagnosed?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Diagnosis involves clinical assessment, imaging studies like chest X-rays or CT scans, and exclusion of other causes of respiratory distress.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors#faq-question-1760092496614","position":2,"url":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors#faq-question-1760092496614","name":"How many cases of ARDS occur annually in the U.S.?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"In 2023, there were approximately 210K incident cases of ARDS in the U.S.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors#faq-question-1760092506971","position":3,"url":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors#faq-question-1760092506971","name":"What is the severity distribution of ARDS cases?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"In 2023, 177K cases were classified as mild, highlighting the varying treatment approaches required.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors#faq-question-1760092517957","position":4,"url":"https:\/\/www.delveinsight.com\/blog\/ards-epidemiological-trends-and-risk-factors#faq-question-1760092517957","name":"Has COVID-19 significantly impacted ARDS prevalence?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"While COVID-19 initially led to a surge in ARDS cases, its impact has diminished as COVID-19 cases have virtually disappeared, with longstanding risk factors now being more prominent.","inLanguage":"en-US"},"inLanguage":"en-US"}]}},"author_meta":{"display_name":"Jatin Vimal","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/jatin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/11\/20114223\/Rising-Acute-Respiratory-Distress-Syndrome-ARDS-Prevalence-Posing-a-Major-Public-Health-Concern-300x183.png","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">acute respiratory distress syndrome<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">ARDS<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">ARDS epidemiology<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">ARDS prevalence<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">COVID-19<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">pneumonia<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Sepsis<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">acute respiratory distress syndrome<\/span>","<span class=\"advgb-post-tax-term\">ARDS<\/span>","<span class=\"advgb-post-tax-term\">ARDS epidemiology<\/span>","<span class=\"advgb-post-tax-term\">ARDS prevalence<\/span>","<span class=\"advgb-post-tax-term\">COVID-19<\/span>","<span class=\"advgb-post-tax-term\">pneumonia<\/span>","<span class=\"advgb-post-tax-term\">Sepsis<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 1 year ago","modified":"Updated 7 months ago"},"absolute_dates":{"created":"Posted on Nov 20, 2024","modified":"Updated on Oct 10, 2025"},"absolute_dates_time":{"created":"Posted on Nov 20, 2024 11:40 am","modified":"Updated on Oct 10, 2025 4:05 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/18553","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=18553"}],"version-history":[{"count":3,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/18553\/revisions"}],"predecessor-version":[{"id":33676,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/18553\/revisions\/33676"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/30391"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=18553"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=18553"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=18553"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=18553"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=18553"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}